Clinical Trials Browser

Phase NA × Graft vs Host Disease × Interferon alpha-2 × Clear all

NCT02185261 2018-06-07

Interferon α for the Therapy of Minimal Residual Disease

Phase NA Unknown

Other hematologic neoplasm

Graft vs Host Disease, Leukemia, Recurrence, Neoplasm, Residual